NUMA1 and cancer: To improve a patient’s quality of life and reduce the costs of cancer diagnosis, numerous researchers have been efforts to apply non-invasive diagnostic tests to find promising urinary cancer biomarkers such as cytokeratin-19, telomerase, and especially nuclear matrix protein-22 (NMP-22) [114]